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Background: Statins improve survival of patients after coronary bypass surgery (CABG), but their effect on graft patency is unclear. We examined 
the direct impact of atorvastatin on vascular redox of saphenous vein grafts (SVG) used for CABG, and explored the underlying mechanisms of its 
vascular effects.
Methods: By using an ex vivo model system, SV grafts from ten patients undergoing CABG were exposed to atorvastatin 0, 5 and 10 μmol/L for 6 
hours. Then vascular O2- was measured by lucigenin chemiluminescence +/- endothelial nitric oxide synthase (eNOS) inhibitor LNAME (to estimate 
eNOS coupling) or NADPH (to estimate NADPH-oxidase activity). The direct O2- scavenging effect of atorvastatin was tested in a cell free system of 
xanthine/xanthine oxidase (X/XO), by using vitamin C as positive control.
Results: Atorvastatin induced a rapid reduction of vascular O2- (Fig. A) and reduced the LNAME-inhibitable O2- generation (Fig. B) in SV grafts ex 
vivo. Moreover, atorvastatin also reduced NADPH-oxidase activity in these vessels (Fig C). Importantly, atorvastatin had direct scavenging effects of 
on O2- produced by X/XO system (Fig. D).
Conclusions: These novel findings suggest that atorvastatin exerts a rapid, direct effect on vascular redox state in human SV grafts used for CABG, 
independently of LDL-mediated mechanism. Moreover, the direct effects of atorvastatin on SV grafts are mediated through the improvement of eNOS 
coupling and the reduction of NADPH oxidase activity in the vascular wall.
